Christian Wallasch
Operationeel Directeur bij Atriva Therapeutics GmbH
Oorsprong van het eerstegraads netwerk van Christian Wallasch
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Atriva Therapeutics GmbH
Atriva Therapeutics GmbH BiotechnologyHealth Technology Atriva Therapeutics GmbH is a biopharmaceutical company that develops host-targeting antiviral therapies. It focuses on the development of new antiviral therapies against different respiratory viral infections. The company was founded by Rainer Lichtenberger and Henrik Luer Lueßen in April 2015 and is headquartered in Tuebingen, Germany.
4
| Holding Company | Biotechnology | 4 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Christian Wallasch via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal | |
NEKTAR THERAPEUTICS | Pharmaceuticals: Major | Corporate Officer/Principal | |
BAYER AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
4SC AG | Biotechnology | Chief Executive Officer | |
IPSEN | Pharmaceuticals: Major | Director/Board Member | |
GALAPAGOS NV | Biotechnology | Chief Tech/Sci/R&D Officer | |
Juniata College | College/University | Undergraduate Degree | |
Webster University | College/University | Graduate Degree | |
Katholieke Universiteit Leuven | College/University | Doctorate Degree | |
VIVORYON THERAPEUTICS N.V. | Biotechnology | Chief Executive Officer | |
University Hospital Antwerp
University Hospital Antwerp Hospital/Nursing ManagementHealth Services University Hospital Antwerp provides clinical, patient care, academic training and scientific research services. The company was is headquartered in Belgium. | Hospital/Nursing Management | Director/Board Member | |
Pfizer GmbH | Corporate Officer/Principal | ||
Julius-Maximilians-Universität Würzburg | College/University | Doctorate Degree | |
Fox School of Business | College/University | Masters Business Admin | |
OMEICOS Therapeutics GmbH
OMEICOS Therapeutics GmbH BiotechnologyHealth Technology OMEICOS Therapeutics GmbH develops small molecules using endogenous protective mechanism for the treatment and prevention of atrial fibrillation. It operates as a biopharmaceutical company developing molecule therapeutics for the prevention and treatment of cardiovascular diseases including atrial fibrillation. The company was founded by Wolf-Hagen Schunck, John R. Falck, Dominik Müller, Robert Fischer and Karen Uhlmann in 2013 and is headquartered in Berlin, Germany. | Biotechnology | Chief Executive Officer | |
Ventaleon GmbH
Ventaleon GmbH Pharmaceuticals: OtherHealth Technology Ventaleon GmbH is a biotechnology company, which engages in the development of inhaled treatments against viral infections. Its products include LASAG (D,L-lysine acetylsalicylate • glycine), a lysin-salt formulation of well known acetyl salicylic acid. The company was founded by Gerhard Scheuch in 2012 and is headquartered in Gauting, Germany. | Pharmaceuticals: Other | Chief Executive Officer | |
Atrin Pharmaceuticals LLC
Atrin Pharmaceuticals LLC BiotechnologyHealth Technology Atrin Pharmaceuticals LLC engages in discovery and development of proprietary medications. It offers ATRN-502, a p53 activator; and ATRN-507, a dual ligand showing specificity and selectivity against cancer cells. The firm also provides Atrize, a platform that offers phenotypic FACS-based screening that is applicable across R&D, clinical applications, and a tool for personalized medicine. The company was founded by Oren Gilad and Kevin D. Smith in 2011 and is headquartered in Doylestown, PA. | Biotechnology | Director/Board Member | |
AKARI THERAPEUTICS, PLC | Biotechnology | Director/Board Member | |
miDIAGNOSTICS NV
miDIAGNOSTICS NV Miscellaneous Commercial ServicesCommercial Services miDIAGNOSTICS NV develops a computer chip powered portable medical laboratory. The company is headquartered in Leuven, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
Drug Discovery & Development Solutions Ltd.
Drug Discovery & Development Solutions Ltd. Miscellaneous Commercial ServicesCommercial Services Drug Discovery & Development Solutions Ltd. engages in the provision of financial services. The company is headquartered in Singapore. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Envisagenics, Inc.
Envisagenics, Inc. BiotechnologyHealth Technology Envisagenics, Inc. engages in developing of artificial intelligence platform for discovering drugs. The company was founded by Maria Luisa Pineda and Martin Akerman and is headquartered in New York, NY. | Biotechnology | Director/Board Member | |
APREA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
sterna biologicals GmbH
sterna biologicals GmbH Pharmaceuticals: MajorHealth Technology Sterna Biologicals GmbH is a German clinical-stage immunology company founded in 2006. The company is based in Marburg, Germany. The company has successfully completed four phase 2a clinical trials in asthma, ulcerative colitis, COPD, and atopic dermatitis. Sterna is focused on developing novel treatments for type 2 chronic inflammatory diseases. | Pharmaceuticals: Major | Chief Executive Officer | |
Kira Biotech Pty Ltd.
Kira Biotech Pty Ltd. BiotechnologyHealth Technology Kira Biotech Pty Ltd. operates as biotechnology company which develops novel immunomodulatory compounds for the treatment of immune system disorders. The company was founded by Georgina Clark is headquartered in Brisbane, Australia. | Biotechnology | Chairman | |
Tibotec-Virco Comm Va | Corporate Officer/Principal | ||
Xinvento BV
Xinvento BV BiotechnologyHealth Technology Part of Rhythm Pharmaceuticals, Inc., Xinvento BV is a Dutch biotech company that develops therapies for congenital hyperinsulinism. The company is based in Amsterdam, Netherlands. The company was founded in 2021 by Claudine van der Sande, Sarah Hafith-de Boer, Piet Wigerinck. Claudine van der Sande has been the CEO since 2021. Xinvento was acquired by Rhythm Pharmaceuticals Netherlands BV on February 27, 2023 for $222.43 million. | Biotechnology | Founder | |
Atrin Pharmaceuticals, Inc.
Atrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Founded in 2012, Atrin Pharmaceuticals, Inc. is a DNA Damage Response development company that focuses on a pipeline of products resulting from a series of novel conformationally restricted macrocyclic molecules. Part of Aprea Therapeutics, Inc., the company is based in Doylestown, PA. Atrin Pharmaceuticals was acquired by Aprea Therapeutics, Inc. on May 16, 2022 for $1.33 million. The company's products have the highest known potency for inhibiting ATR and exhibit ATR selectivity with potential broad therapeutic profile. | Pharmaceuticals: Major | Director/Board Member | |
UZA Foundation | Director/Board Member | ||
Vectura GmbH
Vectura GmbH Medical SpecialtiesHealth Technology Vectura GmbH manufactures and develops pharmaceutical therapies for airways diseases. It offers dry powder formulation technology, device technology, and development capabilities. The company was founded by Gerhard Scheuch in 1997 and is headquartered in Gemünden, Germany. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal |
Statistieken
Internationaal
Verenigde Staten | 13 |
Duitsland | 11 |
België | 7 |
Verenigd Koninkrijk | 2 |
Frankrijk | 2 |
Sectoraal
Health Technology | 22 |
Consumer Services | 6 |
Commercial Services | 3 |
Health Services | 2 |
Finance | 2 |
Operationeel
Director/Board Member | 14 |
Corporate Officer/Principal | 12 |
Independent Dir/Board Member | 7 |
Chief Executive Officer | 6 |
Founder | 2 |
Sterkste connecties
Insiders | |
---|---|
Michael Grissinger | 12 |
Piet Wigerinck | 10 |
Christian Pangratz | 9 |
Ulrich Dauer | 7 |
- Beurs
- Insiders
- Christian Wallasch
- Bedrijfsconnecties